The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)

Publication | Open Access

DOI Full Paper Access

Citations

References

2020

Year

Henrik Wiggers, Lars Køber, Gunnar Gislason, Morten Schou, Mikael Kjær Poulsen, Søren Vraa, Olav Wendelboe Nielsen, Niels Eske Bruun, Helene Nørrelund, Malene Hollingdal,

American Heart Journal

Diabetes ManagementHeart FailureChronic Heart FailureCardiovascular DiseaseAntihypertensive TherapyDiabetesClinical TrialsFactorial TrialPharmacotherapyHydralazine-isosorbide DinitrateCardiac CareDiuretic ResistanceMedicineCardiologyAnesthesiology